AMPL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AMPL is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some constructive signs, but the setup is not compelling enough to call it a clear buy today. With no AI Stock Picker or SwingMax signal, mixed analyst views, high options volatility, and profitability still negative, the better call is to hold and wait for either a stronger catalyst or a more attractive entry. If forced to act now, this is more of a speculative hold than a confident long-term buy.
The stock is in a mild rebound phase but not in a strong uptrend. Price closed at 7.33, slightly above the previous close of 7.18, while the broader market was also positive. RSI_6 at 58.17 is neutral-to-bullish, and MACD histogram is positive at 0.0876, though it is contracting, which suggests momentum is not strengthening aggressively. Moving averages are converging, indicating a sideways-to-slightly constructive trend rather than a decisive trend breakout. Key levels: pivot 6.986, resistance 7.326 and 7.536, support 6.646 and 6.436. The stock is sitting near near-term resistance, so upside from here is possible but not especially strong without a catalyst.
["Revenue in 2025/Q4 increased 17.02% YoY, showing healthy top-line growth.", "Analysts such as BofA, Piper Sandler, Morgan Stanley, UBS, and KeyBanc still maintain bullish ratings despite multiple price target cuts.", "FY26 guidance and recent commentary suggest continued growth momentum in the business.", "Earnings are scheduled for 2026-05-06, which could provide an event-driven catalyst if results and guidance improve."]
["No recent news in the past week, so there is no fresh catalyst today.", "Multiple analysts have cut price targets recently, including BofA, Piper Sandler, Citi, Morgan Stanley, UBS, Baird, and KeyBanc.", "Citi turned more selective and sees a lack of catalysts over the next 12 months.", "Net income and EPS remain negative in the latest quarter, so profitability is still weak.", "Gross margin was essentially flat-to-slightly lower, showing limited margin improvement.", "No significant hedge fund, insider, or congress trading trend is supporting the stock."]
In 2025/Q4, Amplitude delivered revenue of $91.43M, up 17.02% year over year, which is a solid growth rate for a software company. However, profitability remains a concern: net income fell to -$17.66M and EPS declined to -0.13, both worse year over year. Gross margin was 74.63%, only slightly lower than the prior year, suggesting the company is maintaining healthy product economics but still has not translated growth into earnings power. Overall, the latest quarter shows good revenue momentum but weak bottom-line performance.
Analyst sentiment is mixed but still leans positive overall. Recent action shows a clear trend of price target cuts across major firms: BofA cut to $10 from $20, Piper Sandler to $9 from $10, Citi to $7 from $9, Morgan Stanley to $12 from $16, UBS to $10 from $13, Baird to $12 from $15, and KeyBanc to $14 from $16. Despite that, several firms kept Buy/Overweight ratings, which shows Wall Street still sees long-term potential. The bullish case is continued ARR/revenue acceleration and AI traction; the bearish case is execution risk, weak margins, and valuation compression.
